MedTrace Logo

PEARL Study: Improvement of Non-Hodgkin's Lymphoma Care

NCT01562509 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 418

Last updated 2014-11-13

No results posted yet for this study

Summary

The main objective of the proposed study is to assess the effectiveness, feasibility and costs of a tailored strategy (developed in accordance with the barriers found and current practice) to improve care for patients with non-Hodgkin's lymphomas (NHL), compared to a common strategy of 'audit \& feedback'.

Conditions

Interventions

OTHER

Implementation tools

* Professionals receive audit \& feedback * Patients (and clinicians) have access to a website with information tailored to patients with an NHL. This website gives insight into the logistic processes of each diagnostic tool and into the patients' personal care pathway. * Standardization of diagnostic and evaluative request forms and reports for clinicians. * Supporting material for standardizing the procedure for multidisciplinary meetings.

OTHER

Standard intervention

Standard intervention consists of audit\&feedback

Sponsors & Collaborators

  • Radboud University Medical Center

    lead OTHER

Principal Investigators

  • Rosella Hermens, PhD · Radboud University Nijmegen Medical Center

  • Nelleke Ottevanger, MD, PhD · Radboud University Nijmegen Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2014-11-30
Completion
2014-12-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01562509 on ClinicalTrials.gov